New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate cancer cases in patients of European ancestry have a gene rearrangement in ...

Key Takeaways Renaming the lowest-grade prostate cancer to something other than cancer might save men’s livesThese GG1 cases ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.

Early prostate evaluation can detect enlarged prostate and cancer before symptoms worsen, says Dr. Piyush Varshney of Fortis ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

Local community invited to walk with Prostate Cymru from Aberdaron to Pwllheli to raise funds and awareness for prostate ...

When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...